In the face of chronic disease, DTx have the opportunity to provide a lifeline to patients.
Joel Morse
Advertisement
CEO, Curavit Clinical Research
Articles by Joel Morse
How DCTs can impact pharmaceutical companies exploring DTx combination products and standalone DTx studies.
Advertisement
Latest Updated Articles
How Healthcare Economics Outcomes Evidence Can Pave the Way for Digital TherapeuticsPublished: December 21st 2023 | Updated:
Digital Therapeutics and Decentralized Trials: A Match Made in ClinicalPublished: April 13th 2022 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Verana Health Merges With COTA to Expand Real-World Data Capabilities Across Oncology and Specialty Care
2
Why Trial Competition Is Undermining AI-Driven Gains
3
ACT Brief: Recalibrating Trial Efficiency and Access, Verana-COTA Merge to Expand RWE Scale, and FDA Rejects Hetlioz Jet Lag Indication
4
Reasoning About Individual Drug Causality in a Multifactorial World
5